2,9-dimethyl-beta-carbolinium has been researched along with stallimycin in 1 studies
| Studies (2,9-dimethyl-beta-carbolinium) | Trials (2,9-dimethyl-beta-carbolinium) | Recent Studies (post-2010) (2,9-dimethyl-beta-carbolinium) | Studies (stallimycin) | Trials (stallimycin) | Recent Studies (post-2010) (stallimycin) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 485 | 0 | 39 |
| Protein | Taxonomy | 2,9-dimethyl-beta-carbolinium (IC50) | stallimycin (IC50) |
|---|---|---|---|
| GTPase HRas | Homo sapiens (human) | 0.2 | |
| Estrogen receptor | Homo sapiens (human) | 0.02 | |
| Neutrophil elastase | Homo sapiens (human) | 0.2 | |
| DNA topoisomerase 1 | Homo sapiens (human) | 2.7 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denny, WA; Feigon, J; Kearns, DR; Leupin, W | 1 |
1 other study(ies) available for 2,9-dimethyl-beta-carbolinium and stallimycin
| Article | Year |
|---|---|
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1984 |